Adhesion Molecules on Murine Lymphokine‐activated Killer Cells Responsible for Target Cell Killing: A Role of CD2

Lymphokine‐activated killer (LAK) cells were induced from C57BL/6 mouse spleen cells and the effects of culture time on the expression of cell surface phenotypes and cytotoxic activity of LAK cells were determined. The expression of CD2 remarkably decreased after culture of LAK cells for 30 days, while LFA‐1, a principal adhesion molecule in LAK cells, and CD3 were not changed by the culture. LAK cells cultured for 90 days completely lost CD2. In accordance with the decrease of CD2, the cytotoxic activity of LAK cells declined but a certain leven was retained even after the complete loss of CD2. The established LAK cell clones were also strongly positive for the expression of LFA‐1 but negative for CD2. When the LAK cell clones were transfected with the CD2 cDNA, they started to express CD2 on their cell surface and to show greater binding ability and stronger cytotoxicity to target tumor cells. These results indicated that CD2 plays a role as an adhesion molecule responsible for target cell killing in murine LAK cells.

[1]  Kazunori Kato,et al.  Establishment of Mouse Lymphokine‐activated Killer Cell Clones and Their Properties , 1991, Japanese journal of cancer research : Gann.

[2]  R. Siliciano,et al.  Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Sanders,et al.  The CD2-LFA-3 and LFA-1-ICAM pathways: relevance to T-cell recognition. , 1989, Immunology today.

[4]  J. Westwick,et al.  Phorbol esters regulate CD2- and CD3-mediated calcium responses in peripheral blood-derived human T cells. , 1989, Journal of Immunology.

[5]  D. Olive,et al.  T cell activation via the CD2 molecule is associated with protein kinase C translocation from the cytosol to the plasma membrane , 1989, European journal of immunology.

[6]  H. Karasuyama,et al.  Monoclonal antibodies specific for murine CD2 reveal its presence on B as well as T cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Okumura,et al.  CD2 expression in murine B cell lineage. , 1989, International immunology.

[8]  Y. Shimizu,et al.  Two molecular pathways of human T cell adhesion: establishment of receptor-ligand relationship. , 1988, Current opinion in immunology.

[9]  D. Paterson,et al.  Activation of rat T lymphocytes by anti-CD2 monoclonal antibodies , 1988, The Journal of experimental medicine.

[10]  S. Meuer,et al.  Alternative pathway activation of T cells by binding of CD2 to its cell-surface ligand , 1987, Nature.

[11]  Michael Loran Dustin,et al.  The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3 , 1987, Nature.

[12]  Michael Loran Dustin,et al.  Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion , 1987, The Journal of experimental medicine.

[13]  Michael Loran Dustin,et al.  Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3) , 1987, The Journal of experimental medicine.

[14]  B. Haynes,et al.  Thymocyte binding to human thymic epithelial cells is inhibited by monoclonal antibodies to CD-2 and LFA-3 antigens. , 1987, Journal of immunology.

[15]  T. Springer,et al.  Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones , 1986, Nature.

[16]  C. Verret,et al.  Serine esterase in cytolytic T lymphocytes , 1986, Nature.

[17]  R. Bolhuis,et al.  Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor. , 1986, Journal of immunology.

[18]  E. Podack,et al.  Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity , 1986, Cell.

[19]  Y. Hashimoto,et al.  Lymphokine-activated cell-associated antigen involved in broad-reactive killer cell-mediated cytotoxicity. , 1985, Cellular immunology.

[20]  E. Reinherz,et al.  An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein , 1984, Cell.

[21]  Y. Hashimoto,et al.  Induction of nonspecific killer T cells from non-immune mouse spleen cells by culture with interleukin 2. , 1984, Gan.

[22]  F. Sánchez‐Madrid,et al.  The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions. , 1983, Journal of immunology.

[23]  J. Strominger,et al.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Springer,et al.  LFA-1 but not Lyt-2 is associated with killing activity of cytotoxic T lymphocyte hybridomas , 1982, Nature.

[25]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[26]  T. Springer,et al.  Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1): mechanism of blockade of T lymphocyte-mediated killing and effects on other T and B lymphocyte functions. , 1981, Journal of immunology.

[27]  T. Springer,et al.  Lymphocyte function-associated antigen 1 (LFA-1): a surface antigen distinct from Lyt-2,3 that participates in T lymphocyte-mediated killing. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Hashimoto,et al.  Evaluation of cell damage in immune reactions by release of radioactivity from 3 H-uridine labeled cells. , 1971, Gan.